摩通亞太區CEO:印度、澳洲及日本將成明年亞太區增長最快市場
摩通亞太區行政總裁郭利博表示,明年印度、澳洲及日本將成為亞太地區增長最快的三個市場,預計印度可能成為「中國加一」供應鏈多元化策略的最大受惠國家。
目前蘋果(AAPL.US)等跨國公司已增加在印度的生產,郭利博認為,目前印度仍然缺少有規模的基礎設施,相信低端製造業將撤離中國,但高端製造業尚未離開中國。
他續指,尚未看到中國市場活動急劇放緩,而該行的主要客戶是在中國境外經營的國際公司,其業務並未受到地緣政治所影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.